Clinical Trials Logo

Clinical Trial Summary

To compare the effectiveness of two treatment strategies in early rheumatoid arthritis (ERA), namely the delayed usual care and early intensive care, in Hong Kong. - The delayed usual care reflects the usual treatment practice in Hong Kong - The early intensive care includes tight monitoring and immediate adjustment of therapy


Clinical Trial Description

This study is a 1-year non-randomized clinical trial. Two groups of patients (delayed usual care and early intensive care) with diagnosis of rheumatoid arthritis (RA) and with symptoms onset of less than 2 years and disease modifying anti-rheumatic drugs (DMARDs) naive will be recruited. Remission is reached if patients fulfill the Boolean criteria. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01762176
Study type Interventional
Source Chinese University of Hong Kong
Contact
Status Completed
Phase N/A
Start date October 2012
Completion date July 2018

See also
  Status Clinical Trial Phase
Completed NCT01768923 - Early RA Vascular Randomised Controlled Study N/A
Completed NCT01185301 - Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA) Phase 3
Recruiting NCT03755258 - Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid Arthritis Phase 1
Recruiting NCT03389711 - INCMNSZ - Rheumatoid Arthritis Cohort
Completed NCT00195663 - Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis Phase 3
Completed NCT04752748 - Power Doppler in Hand Joints of Early RA Patients